DarioHealth (DRIO) to Release Quarterly Earnings on Thursday

DarioHealth (NASDAQ:DRIO) is set to release its earnings data before the market opens on Thursday, November 7th. Analysts expect DarioHealth to post earnings of ($0.18) per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

DarioHealth (NASDAQ:DRIO) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.51) by $0.43. DarioHealth had a negative net margin of 265.33% and a negative return on equity of 74.64%. The business had revenue of $6.26 million during the quarter, compared to analysts’ expectations of $7.57 million. On average, analysts expect DarioHealth to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

DarioHealth Price Performance

DRIO stock opened at $0.92 on Tuesday. The stock has a market capitalization of $28.82 million, a price-to-earnings ratio of -0.78 and a beta of 1.51. The firm’s 50-day moving average price is $0.94 and its two-hundred day moving average price is $1.17. The company has a current ratio of 2.26, a quick ratio of 1.96 and a debt-to-equity ratio of 0.34. DarioHealth has a 12-month low of $0.71 and a 12-month high of $2.60.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.